Skip to Main Content
CWRU Links

Funding Resources

Recently Announced Funding Opportunities

Request for Proposals for Case CCC Funding for Early Phase Clinical Trials

The Case CCC is encouraging investigators to submit Letters of Intent (LOI) for Early Phase Clinical Research Support (EPCRS) funding. These in-house funds are available for the conduct of early phase (Phase 0, 1, pilot/feasibility) clinical trials of relatively short duration which are focusing on initial early phase testing of a candidate agent or device for the diagnosis, prevention detection or treatment of cancer.
 
This is the last year when EPCRS funds are available in their current form, as such this is the last chance to apply for funding for applicable studies. Proposals are being accepted on a rolling basis. 
 
Please direct any questions and/or submit LOIs to Katarzyna Karelus, Case CCC Clinical Research Office, katarzyna.karelus@case.edu, 216.844.4176.

Opportunities for Pilot Projects that Lead to Applications for Funding through NCI Provocative Questions (RFA-CA-17-017) Initiative

Non-Competitive LOI Deadline: Sep 5, 2017
Full Application Deadline: Sep 11, 2017

The Case Comprehensive Cancer Center is providing seed funding for the initiation or extension of innovative projects that focus on one or more of the NCI provocative questions (PQ) listed in  RFA-CA-17-017. The goal of this funding is to support the collection of preliminary data for submission of R01-level grant applications that specifically address one of the 12 PQs in the RFA. R01 submissions to the National Cancer Institute must occur by October 2018. Collaborative, multi-investigator projects are particularly encouraged. Use of Cancer Center Shared Resources is also strongly preferred.

Limited Submission: Pilot Projects in Non-AIDS Defining Cancers

LOI Deadline: Sep 5, 2017 
Full Application Deadline: Sep 11, 2017
 
With support from a supplement to its NCI P30 grant, the Case Comprehensive Cancer Center in coordination with the CWRU/UH Center for AIDS Research (CFAR) is providing seed funding for the development of cancer research projects focusing on the interface between aging and HIV infection in Non-AIDS Defining Cancers (NADC). The goal of this RFA is to build collaborative projects in cancer biology, aging, immunology, HIV/AIDS, systems biology/informatics, geriatric oncology, geriatric epidemiology, and/or cancer survivorship that will be competitive for nationally-funded multi-PI awards.

AACR SU2C Dream Team Translational Research Grant

LOI Deadline: Sep 5, 2017
Application Deadline: Jan 16, 2018

The  Stand Up To Cancer Dream Team Translational Research Grant will fund a translational cancer research project that will address critical problems in patient care, including prevention strategies for those at risk, and deliver near-term patient benefit through investigation by a multidisciplinary, multi-institutional, collaborative Dream Team of expert investigators.  
The ideas may focus on particular organ sites, patient populations (such as pediatrics) or on innovative methods of treatment. Projects must be designed to accelerate the application of new preventive, diagnostic or therapeutic approaches to the clinic (i.e., lead to patient involvement within 2-3 years from the beginning of the grant). Proposals for Dream Team research projects must present plans indicating how the work will be translated into the clinic. The ideas should be based on perceived opportunities for success as well as high-priority areas with a critical need for rapid progress beyond current medical care. 

Projects Supporting Multi-Investigator Research Programs in Adolescent and Young Adult (AYA) Cancers

LOI Deadline: Sep 11, 2017 
Stage I Deadline: Oct 1, 2017 
 
With support from the Angie Fowler AYA Cancer Research Initiative, the Case Comprehensive Cancer Center is providing seed funding for the development of multi-investigator research programs focused on cancers in the adolescent and young adult (AYA) population (ages 15-30).  Each year in the United States, approximately 70,000 adolescents and young adults are diagnosed with cancer. The goal of this RFA is to support teams of three or more principal investigators who are working to develop and submit a program project or similar level grant application focused on AYA cancers. Research teams must focus on the discovery of novel AYA cancer mechanisms with the expectation that these insights will lead to new diagnostics, prognostics, and/or therapeutics. Teams must provide evidence of an ongoing collaboration, but may also add new participants to the collaborative team.

WM Keck Foundation Research Program

Internal LOI Deadline: Sep 15, 2017 
CWRU Application Deadline: Apr 24, 2018
External Deadline: May 1, 2018
 
The W.M. Keck Foundation Research Program seeks to benefit humanity by funding fundamental, high-risk research in two specific areas: 1) medical research and 2) science and engineering. Both Senior and Early Career investigators are encouraged to apply. 
 
CWRU may submit TWO proposals per funding cycle: one (1) in Medical Research and one (1) in Science and Engineering Research.

Pilot Project Grants: American Cancer Society IRG Awards

LOI Deadline: Thursday, Sep 21, 2017
Application Deadline: Monday, October 9, 2017
  • Pilot funding for cancer-related research in basic, clinical, prevention & control, behavioral, health services and epidemiology.
  • Up to $30,000 award.
  • Applications accepted for general cancer-related projects and for special interest projects in adolescent-and-young-adult cancer research.

Department of Defense (DOD) Breast Cancer Research Program (BCRP)

Pre-Application: Nov 21, 2017
Application: Dec 6, 2017
 
Pre-Application: Sep 29, 2017 
Invited Application: Dec 21, 2017
 
Pre-Application: Nov 21, 2017
Application: Dec 6, 2017
 
Pre-Application: Sep 29, 2017
Invited Application: Dec 21, 2017
Pre-Application: Sep 29, 2017
Invited Application: Dec 21, 2017
Pre-Application: Nov 21, 2017
Application: Dec 6, 2017